Omicron

Omicron Biochemicals is a specialized life sciences company that focuses on the synthesis of stable isotope-labeled biological compounds. Founded in 1982 and based in South Bend, Indiana, the company is a global leader in providing high-purity carbohydrates, nucleosides, and their derivatives labeled with Carbon-13, Nitrogen-15, and Deuterium. These specialized molecules are essential tools for researchers in metabolic studies, structural biology, and drug discovery. Omicron serves a diverse clientele including academic institutions, pharmaceutical companies, and government research laboratories. The company is recognized for its expertise in complex chemical and enzymatic synthesis, enabling the production of site-specific labeled compounds that are often unavailable elsewhere.